Genetic mutations warn of skin cancer risk: New high-risk cancer causing mutation identified for melanoma development
3/31/2014

Researchers have discovered that mutations in a specific gene are responsible for a hereditary form of melanoma.Every year in the UK, almost 12,000 people are diagnosed with melanoma, a form of skin cancer. About 1 in 20 people with melanoma have a strong family history of the disease.

Queen's University discovery signals new treatment for women at high risk of breast and ovarian cancer
3/31/2014

Cancer researchers at Queen's University Belfast have made a breakthrough which could signal new treatments for women at high risk of breast and ovarian cancer.Currently around one in 1,000 women in the UK carry what is known as a BRCA1 mutation - the same condition that prompted well-known actress Angelina Jolie to undergo a double mastectomy.

Novel study into breast cancer origins paves way for personalised treatment
3/31/2014

Breast cancers can look and behave very differently. Understanding why and how they do so is key to designing more tailored therapies for patients and sparing them unnecessary treatments.In a new study published by the Journal of Pathology, Dr Matt Smalley from Cardiff University treads new ground in exploring what drives breast cancers to look and behave so differently from one another.

Blood Clot Alliance asks Congress for $4 million to save 100,000 lives a year
3/31/2014

The National Blood Clot Alliance (NBCA) is calling on Congress for $4 million in each of the next five years to support better awareness and avoidance of blood clots.

New finding could lead to more accurate breast cancer prognosis
3/31/2014

The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UC San Francisco researchers have found in a new study.

Discovery signals new treatment for those at high risk of breast and ovarian cancer
3/31/2014

Cancer researchers at Queen's University Belfast have made a breakthrough which could signal new treatments for women at high risk of breast and ovarian cancer.Currently around one in 1,000 women in the UK carry what is known as a BRCA1 mutation - the same condition that prompted well-known actress Angelina Jolie to undergo a double mastectomy.

New diagnostic test for bowel diseases
3/31/2014

A novel method for distinguishing different types of bowel disease using the stool samples of patients has been created by a group of researchers in the UK.It works by analysing the chemical compounds emitted from the samples and could provide cheaper, quicker and more accurate diagnoses, at the point of care, for a group of diseases that have, up until now, been very hard to distinguish.

Improving understanding of circadian clock mechanisms
3/31/2014

You've switched to the night shift and your weight skyrockets, or you wake at 7 a.m. on weekdays but sleep until noon on weekends - a social jet lag that can fog your Saturday and Sunday.

Closely observing the multiplication of cells
3/31/2014

Our cells must grow and divide optimally to ensure that our bodies functions properly. It is essential, however, that these processes are carefully controlled in order to prevent unrestrained proliferation that can lead to the formation of tumours.

Potential target identified for treating mitochondrial disorders
3/31/2014

Mitochondria, long known as "cellular power plants" for their generation of the key energy source adenosine triphosphate (ATP), are essential for proper cellular functions.